» Articles » PMID: 27689993

Elevated Expression of Calpain-4 Predicts Poor Prognosis in Patients with Gastric Cancer After Gastrectomy

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2016 Oct 1
PMID 27689993
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Calpain-4 belongs to the calpain family of calcium-dependent cysteine proteases, and functions as a small regulatory subunit of the calpains. Recent evidence indicates that calpain-4 plays critical roles in tumor migration and invasion. However, the roles of calpain-4 in gastric tumorigenesis remain poorly understood. Herein, we examined calpain-4 expression by immunohistochemical staining on tissue microarrays containing tumor samples of 174 gastric cancer patients between 2004 and 2008 at a single center. The Kaplan-Meier method was used to compare survival curves, and expression levels were correlated to clinicopathological factors and overall survival. Our data demonstrated that calpain-4 was generally increased in gastric cancer cell lines and primary tumor tissues. High expression of calpain-4 was positively associated with vessel invasion, lymph node metastasis, and advanced TNM (Tumor Node Metastasis) stage. Multivariate analysis identified calpain-4 as an independent prognostic factor for poor prognosis. A predictive nomogram integrating calpain-4 expression with other independent prognosticators was constructed, which generated a better prognostic value for overall survival of gastric cancer patients than a TNM staging system. In conclusion, calpain-4 could be regarded as a potential prognosis indicator for clinical outcomes in gastric cancer.

Citing Articles

Clear Cell Renal Carcinoma: MicroRNAs With Efficacy in Preclinical Models.

Weidle U, Nopora A Cancer Genomics Proteomics. 2021; 18(3 Suppl):349-368.

PMID: 33994361 PMC: 8240043. DOI: 10.21873/cgp.20265.


Deciphering the Role of Ca Signalling in Cancer Metastasis: From the Bench to the Bedside.

Alharbi A, Zhang Y, Parrington J Cancers (Basel). 2021; 13(2).

PMID: 33430230 PMC: 7825727. DOI: 10.3390/cancers13020179.


Calpain Small Subunit 1 Protein in the Prognosis of Cancer Survivors and Its Clinicopathological Correlation.

Tang S, Yin Q, Liu F, Zhang Y Biomed Res Int. 2020; 2019:8053706.

PMID: 32083121 PMC: 7012277. DOI: 10.1155/2019/8053706.


High expression of Capn4 is associated with metastasis and poor prognosis in esophageal squamous cell carcinoma.

Wu X, Zhang H, Chen C, Gong L, Wang Y, Zhu X Int J Clin Exp Pathol. 2020; 11(2):765-772.

PMID: 31938163 PMC: 6957994.


Development and Validation of a Nomogram to Predict the Benefit of Adjuvant Radiotherapy for Patients with Resected Gastric Cancer.

Yuan S, Wu W, Qiu M, Wang Z, Yang L, Jin Y J Cancer. 2017; 8(17):3498-3505.

PMID: 29151934 PMC: 5687164. DOI: 10.7150/jca.19879.

References
1.
Zhang C, Bai D, Huang X, Shi G, Ke A, Yang L . Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinoma. PLoS One. 2013; 8(1):e54619. PMC: 3551843. DOI: 10.1371/journal.pone.0054619. View

2.
Lim L, Michael M, Mann G, Leong T . Adjuvant therapy in gastric cancer. J Clin Oncol. 2005; 23(25):6220-32. DOI: 10.1200/JCO.2005.11.593. View

3.
Zhuang Q, Qian X, Cao Y, Fan M, Xu X, He X . Capn4 mRNA level is correlated with tumour progression and clinical outcome in clear cell renal cell carcinoma. J Int Med Res. 2014; 42(2):282-91. DOI: 10.1177/0300060513505524. View

4.
Rios-Doria J, Kuefer R, Ethier S, Day M . Cleavage of beta-catenin by calpain in prostate and mammary tumor cells. Cancer Res. 2004; 64(20):7237-40. DOI: 10.1158/0008-5472.CAN-04-1048. View

5.
Dourdin N, Bhatt A, Dutt P, Greer P, Arthur J, Elce J . Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts. J Biol Chem. 2001; 276(51):48382-8. DOI: 10.1074/jbc.M108893200. View